Recent studies showed that obesity-induced hepatic steatosis and WAT-associated inflammation are accompanied with increased CD44 expression and opened the possibility that CD44 might play a regulatory role in obesity and associated pathologies [20], [21]. The gene discussed is CD44; the disease is obesity disorder.